Cargando…

Impact of Latanoprost Antiglaucoma Eyedrops and Their Excipients on Toxicity and Healing Characteristics in the Ex Vivo Eye Irritation Test System

INTRODUCTION: Corneal epithelial toxicity and delayed healing process have already been attributed to preservatives or some excipients. We study the effects of galenic components in antiglaucoma drugs such as benzalkonium chloride (BAC) or surfactants like macrogolglycerol hydroxystearate 40 (MGHS 4...

Descripción completa

Detalles Bibliográficos
Autores principales:	Panfil, Claudia, Chauchat, Laure, Guerin, Camille, Rebika, Hayette, Sahyoun, Marwan, Schrage, Norbert
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2023
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10441994/ https://www.ncbi.nlm.nih.gov/pubmed/37486574 http://dx.doi.org/10.1007/s40123-023-00769-y

Ejemplares similares

Comparison of In Vitro Corneal Permeation and In Vivo Ocular Bioavailability in Rabbits of Three Marketed Latanoprost Formulations
por: Chauchat, Laure, et al.
Publicado: (2023)

Efficacy and safety of a switch to latanoprost 0.005% + timolol maleate 0.5% fixed combination eyedrops from latanoprost 0.005% monotherapy
por: Inoue, Kenji, et al.
Publicado: (2012)

Efficacy and Safety of Preservative-free Latanoprost Eyedrops Compared with Preserved Prostaglandin Analogues in Patients with Open-angle Glaucoma
por: Seong, Hyo Jin, et al.
Publicado: (2021)

Antiglaucoma pharmacotherapy
por: Tătaru, CP, et al.
Publicado: (2012)

Efficacy and safety of switching to latanoprost 0.005%–timolol maleate 0.5% fixed-combination eyedrops from an unfixed combination for 36 months
por: Inoue, Kenji, et al.
Publicado: (2014)

The Effect of High Molecular Weight Hyaluronic Acid and Latanoprost Eyedrops on Tear Functions and Ocular Surface Status in C57/BL6 Mice
por: Dogru, Murat, et al.
Publicado: (2023)

Corneal Epithelial Wound Healing Promoted by Verbascoside-Based Liposomal Eyedrops
por: Ambrosone, Luigi, et al.
Publicado: (2014)

The Effect of Antiglaucoma Procedures (Trabeculectomy vs. Ex-PRESS Glaucoma Drainage Implant) on the Corneal Biomechanical Properties
por: Konstantinidis, Aristeidis, et al.
Publicado: (2021)

Spironolactone Eyedrop Favors Restoration of Corneal Integrity after Wound Healing in the Rat
por: Rodrigues-Braz, Daniela, et al.
Publicado: (2023)

Controversy: Is Benzalkonium Chloride Necessary in Antiglaucoma Drops?
por: Louati, Y, et al.
Publicado: (2012)

Antioxidant, Antidiabetic, Anticholinergic, and Antiglaucoma Effects of Magnofluorine
por: Durmaz, Lokman, et al.
Publicado: (2022)

Effect of Autologous Serum Eyedrops on Ocular Surface Disease Caused by Preserved Glaucoma Eyedrops
por: So, Ha-Rim, et al.
Publicado: (2020)

Comparison of Efficacy and Ocular Surface Disease Index Score between Bimatoprost, Latanoprost, Travoprost, and Tafluprost in Glaucoma Patients
por: El Hajj Moussa, Wissam Georges, et al.
Publicado: (2018)

Defining corneal chemical burns: A novel exact and adjustable ocular model
por: Glaudo, Markus, et al.
Publicado: (2021)

Spruce Balm-Based Semisolid Vehicles for Wound Healing: Effect of Excipients on Rheological Properties and Ex Vivo Skin Permeation
por: Eichenauer, Elisabeth, et al.
Publicado: (2023)

Antiglaucoma drugs for achieving monovision after laser in situ keratomileusis
por: Kamiya, Kazutaka, et al.
Publicado: (2009)

A Novel Convergent Synthesis of the Potent Antiglaucoma Agent Tafluprost
por: Krupa, Małgorzata, et al.
Publicado: (2017)

Changes in Corneal Epithelial Thickness Induced by Topical Antiglaucoma Medications
por: Nam, Myungsik, et al.
Publicado: (2021)

Latanoprost in the treatment of glaucoma
por: Alm, Albert
Publicado: (2014)

Efficacy and Safety of Switching Latanoprost Monotherapy to Bimatoprost Monotherapy or Combination of Brinzolamide and Latanoprost
por: Imasawa, Mitsuhiro, et al.
Publicado: (2016)

Delineation of LASIK Flaps with Prednisolone Acetate Eyedrops
por: Fahd, Daoud C, et al.
Publicado: (2014)

Hirsutism following the use of bimatoprost eyedrops for glaucoma
por: Kaliaperumal, Subashini, et al.
Publicado: (2014)

Allergic contact dermatitis caused by dorzolamide eyedrops
por: Lee, Seung-Jun, et al.
Publicado: (2015)

Corneal epithelial toxicity of antiglaucoma formulations: in vitro study of repeated applications
por: Meloni, Marisa, et al.
Publicado: (2012)

Safety comparison of additives in antiglaucoma prostaglandin (PG) analog ophthalmic formulations
por: Fukuda, Masamichi, et al.
Publicado: (2013)

Corneal Opacity Induced by Antiglaucoma Agents Other Than Brimonidine Tartrate
por: Kasuya, Yuka, et al.
Publicado: (2020)

Effect of Long-Term Topical Antiglaucoma Medication Use on the Ocular Surface
por: Awe, Oluwaseun Olaniyi, et al.
Publicado: (2020)

Excipients
Publicado: (1878)

The Effects of Topical Antiglaucoma Drugs as Monotherapy on the Ocular Surface: A Prospective Study
por: Aydin Kurna, Sevda, et al.
Publicado: (2014)

Contamination of multi dose eyedrops in the intra and perioperative context
por: Daehn, Tristan, et al.
Publicado: (2021)

Is it time for a moratorium on the use of benzalkonium chloride in eyedrops?
por: D'andrea, Luca, et al.
Publicado: (2022)

Glycerine as an Excipient
Publicado: (1885)

Lanolin as an Excipient
Publicado: (1907)

Influence of Latanoprost on Retinal Microcirculation in Glaucoma
por: Kremmer, S, et al.
Publicado: (2014)

Prostaglandin-associated periorbitopathy in latanoprost users
por: Nakakura, Shunsuke, et al.
Publicado: (2014)

Latanoprost could exacerbate the progression of presbyopia
por: Ayaki, Masahiko, et al.
Publicado: (2019)

Toxicity of antiglaucoma drugs with and without benzalkonium chloride to cultured human corneal endothelial cells
por: Ayaki, Masahiko, et al.
Publicado: (2010)

Use Pattern of Ophthalmic Antiglaucoma Agents with and without Preservatives: A Cross-Sectional Study
por: Valladales-Restrepo, Luis Fernando, et al.
Publicado: (2023)

Comparison between bimatoprost and latanoprost-timolol fixed combination for efficacy and safety after switching patients from latanoprost
por: Maruyama, Yuko, et al.
Publicado: (2015)

Comparison of Netarsudil/Latanoprost Therapy with Latanoprost Monotherapy for Lowering Intraocular Pressure: A Systematic Review and Meta-analysis
por: Lee, Jong-Wook, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_4c40psbvvs28dtgib4mjqojruu